Teleflex Incorporated Teleflex Incorporated

Teleflex Incorporated

TFX

주식 순위 #3230
Teleflex Incorporated is a global medical technology company dedicated to... Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
주가
$130.11
시가총액
$5.51B
변동 (1일)
0.40%
변동 (1년)
-0.33%
국가
US
거래 Teleflex Incorporated (TFX)

카테고리

Healthcare
Teleflex Incorporated (TFX)의 P/E 비율
October 2026 기준 P/E 비율 TTM: -5.30
Teleflex Incorporated의 최신 재무 보고서와 주가에 따르면 현재 P/E (TTM) 비율은 -5.30입니다. 2023년 말 기준 P/E 비율은 32.87였습니다.
Teleflex Incorporated의 P/E 비율 기록 (2000 ~ 2026)
매년 말 P/E 비율
연도 P/E 비율 변화
2026 (TTM) -5.30 -104.43%
2024 119.64 263.93%
2023 32.87 1.97%
2022 32.24 1.85%
2021 31.65 -44.52%
2020 57.06 51.40%
2019 37.69 -35.92%
2018 58.81 -19.89%
2017 73.41 149.60%
2016 29.41 31.84%
2015 22.31 -11.85%
2014 25.31 -1.03%
2013 25.57 -266.80%
2012 -15.33 -299.68%
2011 7.68 -28.10%
2010 10.68 51.16%
2009 7.06 -57.34%
2008 16.56 -1.95%
2007 16.89 -8.27%
2006 18.41 -3.49%
2005 19.08 -91.25%
2004 218.11 1,134.01%
2003 17.68 32.21%
2002 13.37 -18.05%
2001 16.31 5.58%
2000 15.45 0.00%
유사 기업 또는 경쟁사의 P/E 비율
회사 P/E 비율 P/E 비율 차이 국가
47.48 -996.61%
US
27.43 -617.86%
FR
- -
JP
56.89 -1,174.29%
US
- -
CH
P/E 비율 읽는 방법

P/E 비율은 회사의 주가와 주당순이익 간의 관계를 측정합니다.
낮지만 양수인 P/E는 현재 가치 대비 높은 수익을 내고 있는 저평가된 기업을 의미합니다. 높은 음수(0에 가까운) P/E는 큰 손실을 나타냅니다.

P/E가 30을 초과하거나 음수인 기업은 일반적으로 '성장주'로 간주되며, 투자자들은 향후 수익성 개선을 기대합니다.

양의 P/E가 10 미만인 기업은 일반적으로 '가치주'로 간주되며, 이미 매우 수익성이 높고 향후 큰 성장은 기대되지 않습니다.